These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 14623730)

  • 1. Diffusion-weighted magnetic resonance imaging and identification of the epileptogenic tuber in patients with tuberous sclerosis.
    Jansen FE; Braun KP; van Nieuwenhuizen O; Huiskamp G; Vincken KL; van Huffelen AC; van der Grond J
    Arch Neurol; 2003 Nov; 60(11):1580-4. PubMed ID: 14623730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG-PET/MRI coregistration and diffusion-tensor imaging distinguish epileptogenic tubers and cortex in patients with tuberous sclerosis complex: a preliminary report.
    Chandra PS; Salamon N; Huang J; Wu JY; Koh S; Vinters HV; Mathern GW
    Epilepsia; 2006 Sep; 47(9):1543-9. PubMed ID: 16981871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between electroencephalographic and magnetic resonance imaging findings in tuberous sclerosis complex.
    Gallagher A; Chu-Shore CJ; Montenegro MA; Major P; Costello DJ; Lyczkowski DA; Muzykewicz D; Doherty C; Thiele EA
    Epilepsy Res; 2009 Dec; 87(2-3):197-202. PubMed ID: 19783123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography with α-[11C]methyl-L-tryptophan in tuberous sclerosis complex-related epilepsy.
    Rubí S; Costes N; Heckemann RA; Bouvard S; Hammers A; Martí Fuster B; Ostrowsky K; Montavont A; Jung J; Setoain X; Catenoix H; Hino K; Liger F; Le Bars D; Ryvlin P
    Epilepsia; 2013 Dec; 54(12):2143-50. PubMed ID: 24304437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative and quantitative evaluation for the heterogeneity of cortical tubers using structural imaging and diffusion-weighted imaging to predict the epileptogenicity in tuberous sclerosis complex patients.
    Yogi A; Hirata Y; Linetsky M; Ellingson BM; Salamon N
    Neuroradiology; 2023 Apr; 65(4):845-853. PubMed ID: 36456893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topographical Distribution of Epileptogenic Tubers in Patients With Tuberous Sclerosis Complex.
    Ellingson BM; Hirata Y; Yogi A; Karavaeva E; Leu K; Woodworth DC; Harris RJ; Enzmann DR; Wu JY; Mathern GW; Salamon N
    J Child Neurol; 2016 Apr; 31(5):636-45. PubMed ID: 26472749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberous sclerosis: localizing the epileptogenic tuber with synthetic aperture magnetometry with excess kurtosis analysis.
    Canuet L; Ishii R; Iwase M; Kurimoto R; Ikezawa K; Azechi M; Wataya-Kaneda M; Takeda M
    J Clin Neurosci; 2008 Nov; 15(11):1296-8. PubMed ID: 18778940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurite orientation dispersion and density imaging parameters may help for the evaluation of epileptogenic tubers in tuberous sclerosis complex patients.
    Shao X; Zhang X; Xu W; Zhang Z; Zhang J; Guo H; Jiang T; Zhang W
    Eur Radiol; 2021 Aug; 31(8):5605-5614. PubMed ID: 33693995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epilepsy surgery outcome in children with tuberous sclerosis complex evaluated with alpha-[11C]methyl-L-tryptophan positron emission tomography (PET).
    Kagawa K; Chugani DC; Asano E; Juhász C; Muzik O; Shah A; Shah J; Sood S; Kupsky WJ; Mangner TJ; Chakraborty PK; Chugani HT
    J Child Neurol; 2005 May; 20(5):429-38. PubMed ID: 15971355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion tensor imaging identifies changes in normal-appearing white matter within the epileptogenic zone in tuberous sclerosis complex.
    Widjaja E; Simao G; Mahmoodabadi SZ; Ochi A; Snead OC; Rutka J; Otsubo H
    Epilepsy Res; 2010 May; 89(2-3):246-53. PubMed ID: 20129760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DTI of tuber and perituberal tissue can predict epileptogenicity in tuberous sclerosis complex.
    Yogi A; Hirata Y; Karavaeva E; Harris RJ; Wu JY; Yudovin SL; Linetsky M; Mathern GW; Ellingson BM; Salamon N
    Neurology; 2015 Dec; 85(23):2011-5. PubMed ID: 26546629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography.
    Chugani DC; Chugani HT; Muzik O; Shah JR; Shah AK; Canady A; Mangner TJ; Chakraborty PK
    Ann Neurol; 1998 Dec; 44(6):858-66. PubMed ID: 9851429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are cortical tubers epileptogenic? Evidence from electrocorticography.
    Major P; Rakowski S; Simon MV; Cheng ML; Eskandar E; Baron J; Leeman BA; Frosch MP; Thiele EA
    Epilepsia; 2009 Jan; 50(1):147-54. PubMed ID: 19125835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodality imaging for improved detection of epileptogenic foci in tuberous sclerosis complex.
    Asano E; Chugani DC; Muzik O; Shen C; Juhász C; Janisse J; Ager J; Canady A; Shah JR; Shah AK; Watson C; Chugani HT
    Neurology; 2000 May; 54(10):1976-84. PubMed ID: 10822440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can diffusion tensor imaging (DTI) identify epileptogenic tubers in tuberous sclerosis complex? Correlation with α-[11C]methyl-L-tryptophan ([11C] AMT) positron emission tomography (PET).
    Tiwari VN; Kumar A; Chakraborty PK; Chugani HT
    J Child Neurol; 2012 May; 27(5):598-603. PubMed ID: 22140131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different MRI-defined tuber types in tuberous sclerosis complex: Quantitative evaluation and association with disease manifestations.
    Jesmanas S; Norvainytė K; Gleiznienė R; Šimoliūnienė R; Endzinienė M
    Brain Dev; 2018 Mar; 40(3):196-204. PubMed ID: 29258718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of epileptogenic networks in children with tuberous sclerosis complex using EEG-fMRI.
    Jacobs J; Rohr A; Moeller F; Boor R; Kobayashi E; LeVan Meng P; Stephani U; Gotman J; Siniatchkin M
    Epilepsia; 2008 May; 49(5):816-25. PubMed ID: 18177362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epileptogenicity in tuberous sclerosis complex: A stereoelectroencephalographic study.
    Neal A; Ostrowsky-Coste K; Jung J; Lagarde S; Maillard L; Kahane P; Touraine R; Catenoix H; Montavont A; Isnard J; Arzimanoglou A; Bartolomei F; Guenot M; Rheims S
    Epilepsia; 2020 Jan; 61(1):81-95. PubMed ID: 31860139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lateralized interictal epileptiform discharges during rapid eye movement sleep correlate with epileptogenic hemisphere in children with intractable epilepsy secondary to tuberous sclerosis complex.
    Ochi A; Hung R; Weiss S; Widjaja E; To T; Nawa Y; Shima T; Go C; Akiyama T; Donner E; Drake J; Rutka JT; Snead OC; Otsubo H
    Epilepsia; 2011 Nov; 52(11):1986-94. PubMed ID: 21801167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of tuber size for complications of tuberous sclerosis complex.
    Pascual-Castroviejo I; Hernández-Moneo JL; Pascual-Pascual SI; Viaño J; Gutiérrez-Molina M; Velazquez-Fragua R; Quiñones Tapia D; Morales Bastos C
    Neurologia; 2013; 28(9):550-7. PubMed ID: 23274119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.